Biocompatibility and drug delivery systems
Abstract
Drug delivery technology has emerged as an important focus of biotechnological research and commercial enterprise. While much attention is justifiably focused on the design and effectiveness of drug delivery devices, the nature of their interaction with surrounding tissues – their biocompatibility – is crucial. Here we discuss biocompatibility, specifically as it relates to drug delivery systems, which differ from other biomaterial-based devices by possibly containing large quantities of drugs with their own effects on tissues.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Nanometer-sized materials with high biocompatibility and biodegradability are considered excellent drug delivery systems for biomedical applications.
“Ideally, nanometer-sized materials with high biocompatibility8 and biodegradability9 are considered excellent drug delivery systems for biomedical applications.10”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [8]
Cites
Fabrication of novel biomaterials through molecular self-assembly
Zhang, S. (2003) · Nature Biotechnology · doi:10.1038/nbt874 · Cited by 3,353 · see citing works
On the mechanisms of biocompatibility
Williams, D. F. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.023 · Cited by 2,772 · see citing works
Selective Differentiation of Neural Progenitor Cells by High-Epitope Density Nanofibers
Silva, G. A., Czeisler, C. M., Niece, K. L., Beniash, E., Harrington, D. A., Kessler, J. A., & Stupp, S. I. (2004) · Science · doi:10.1126/science.1093783 · Cited by 2,169 · see citing works
New Challenges in Biomaterials
Peppas, N. A., & Langer, R. (1994) · Science · doi:10.1126/science.8134835 · Cited by 1,145 · see citing works
Self-citationNanostructured materials for applications in drug delivery and tissue engineering
Goldberg, M. S., Langer, R., & Jia, X. (2007) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856207779996931 · Cited by 1,057 · see citing works
Self-citationWilliams, D. F. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.027 · Cited by 915 · see citing works
Studies on succinate-tetrazolium reductase systems
Slater, T. F., SAWYER, B. C., & Sträuli, U. (1963) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(63)90513-4 · Cited by 777 · see citing works
Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells
Anderson, D. G., Levenberg, S., & Langer, R. (2004) · Nature Biotechnology · doi:10.1038/nbt981 · Cited by 747 · see citing works
Self-citationThe biocompatibility of mesoporous silicates
Hudson, S. P., Padera, R. F., Langer, R., & Kohane, D. S. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.007 · Cited by 538 · see citing works
Self-citationCell‐Responsive Synthetic Hydrogels
Lütolf, M. P., Raeber, G. P., Zisch, A. H., Tirelli, N., & Hubbell, J. A. (2003) · Advanced Materials · doi:10.1002/adma.200304621 · Cited by 526 · see citing works
Microparticles and nanoparticles for drug delivery
Kohane, D. S. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21301 · Cited by 517 · see citing works
Self-citationClinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review
Böstman, O. M., & PIHLAJAMÄKI, H. K. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00129-0 · Cited by 509 · see citing works
Synthesis and RGD peptide modification of a new biodegradable copolymer: poly(lactic acid-co-lysine)
Barrera, D. A., Zylstra, E., Lansbury, P. T., & Langer, R. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00076a077 · Cited by 456 · see citing works
Self-citationCiolino, J. B., Hoare, T. R., Iwata, N. G., Behlau, I., Dohlman, C. H., Langer, R., & Kohane, D. S. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2826 · Cited by 248 · see citing works
Self-citationYeo, Y., Highley, C. B., Bellas, E., et al. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.04.043 · Cited by 229 · see citing works
Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum
Kohane, D. S., Tse, J. Y., Yeo, Y., et al. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30654 · Cited by 218 · see citing works
Self-citationProlongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid
Jia, X., Colombo, G., Padera, R. F., Langer, R., & Kohane, D. S. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.12.012 · Cited by 191 · see citing works
Self-citationGlucocorticoids Prolong Rat Sciatic Nerve Blockade In Vivo from Bupivacaine Microspheres
Castillo, J., Curley, J., Hotz, J., et al. (1996) · Anesthesiology · doi:10.1097/00000542-199611000-00025 · Cited by 178 · see citing works
Current trends in biocompatibility testing
Kirkpatrick, C. J., Bittinger, F., Wagner, M., Köhler, H., van Kooten, T. G., Klein, C. L., & Otto, M. (1998) · Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine · doi:10.1243/0954411981533845 · Cited by 145 · see citing works
A Re-examination of Tetrodotoxin for Prolonged Duration Local Anesthesia
Kohane, D. S., Yieh, J., Lu, N. T., et al. (1998) · Anesthesiology · doi:10.1097/00000542-199807000-00019 · Cited by 144 · see citing works
Self-citationProlonged duration local anesthesia with minimal toxicity
Epstein-Barash, H., Shichor, I., Kwon, A. H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900598106 · Cited by 143 · see citing works
Injectable in situ cross-linking hydrogels for local antifungal therapy
Hudson, S. P., Langer, R., Fink, G. R., & Kohane, D. S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.016 · Cited by 138 · see citing works
Self-citationIto, T., Fraser, I. P., Yeo, Y., Highley, C. B., Bellas, E., & Kohane, D. S. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.12.012 · Cited by 129 · see citing works
Self-citationProlonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres
Kohane, D. S., Smith, S. E., Louis, D. N., et al. (2003) · Pain · doi:10.1016/s0304-3959(03)00049-6 · Cited by 123 · see citing works
Self-citationPolymers in the prevention of peritoneal adhesions
Yeo, Y., & Kohane, D. S. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.03.027 · Cited by 118 · see citing works
Self-citationZumbuehl, A., Ferreira, L., Kuhn, D. M., Astashkina, A. I., Long, L. A., Yeo, Y., Iaconis, T., Ghannoum, M. A., Fink, G. R., Langer, R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705250104 · Cited by 117 · see citing works
Self-citationIn vivo biocompatibility of implantable delivery systems and biomaterials
Anderson, J. M. (1994) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 116 · see citing works
van der Elst, M., Klein, C. P. A. T., Hogervorst, J. M. A., Patka, P., & Haarman, H. J. T. M. (1999) · Biomaterials · doi:10.1016/s0142-9612(98)00117-3 · Cited by 109 · see citing works
Local Myotoxicity from Sustained Release of Bupivacaine from Microparticles
Padera, R. F., Bellas, E., Tse, J. Y., et al. (2008) · Anesthesiology · doi:10.1097/aln.0b013e31816c8a48 · Cited by 107 · see citing works
Yeo, Y., Ito, T., Bellas, E., et al. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000251519.49405.55 · Cited by 106 · see citing works
Biocompatibility of lipid‐protein‐sugar particles containing bupivacaine in the epineurium
Kohane, D. S., Lipp, M. M., Kinney, R. C., et al. (2001) · Journal of Biomedical Materials Research · doi:10.1002/jbm.1261 · Cited by 99 · see citing works
Self-citationTetrodotoxin for prolonged local anesthesia with minimal myotoxicity
Padera, R. F., Tse, J. Y., Bellas, E., et al. (2006) · Muscle & Nerve · doi:10.1002/mus.20618 · Cited by 79 · see citing works
Peritoneal application of chitosan and UV‐cross‐linkable chitosan
Yeo, Y., Burdick, J. A., Highley, C. B., Marini, R. P., Langer, R., & Kohane, D. S. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30740 · Cited by 70 · see citing works
Self-citationpH-Triggered Microparticles for Peptide Vaccination
Haining, W. N., Anderson, D. G., Little, S. R., von Berwelt-Baildon, M. S., Cardoso, A. A., Alves, P. M. S., Kosmatopoulos, K., Nadler, L. M., Langer, R., & Kohane, D. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2578 · Cited by 68 · see citing works
Self-citationYeo, Y., Adil, M. M., Bellas, E., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.016 · Cited by 65 · see citing works
Colombo, G., Padera, R. F., Langer, R., et al. (2005) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30443 · Cited by 61 · see citing works
Self-citationSciatic Nerve Blockade with Lipid-Protein-Sugar Particles Containing Bupivacaine
Kohane, D. S., Lipp, M. M., Kinney, R. C., et al. (2000) · Pharmaceutical Research · doi:10.1023/a:1026470831256 · Cited by 58 · see citing works
Self-citationYeo, Y., Bellas, E., Highley, C. B., et al. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.04.033 · Cited by 53 · see citing works
Orita, H., Fukasawa, M., Girgis, W., et al. (1991) · PubMed · Cited by 50 · see citing works
The state-of-the-art in predictive toxicogenomics.
Fielden, M. R., & Kolaja, K. L. (2006) · PubMed · Cited by 47 · see citing works
Effect of Chemical Permeation Enhancers on Nerve Blockade
Simons, E. J., Bellas, E., Lawlor, M. W., et al. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800167a · Cited by 46 · see citing works
Lipid–sugar particles for intracranial drug delivery: safety and biocompatibility
Kohane, D. S., Plesnila, N., Thomas, S. S., et al. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02878-0 · Cited by 39 · see citing works
Self-citationPolymers for intracellular delivery of nucleic acids
Little, S. R., & Kohane, D. S. (2007) · Journal of Materials Chemistry · doi:10.1039/b712930k · Cited by 33 · see citing works
Self-citationColombo, G., Langer, R., & Kohane, D. S. (2004) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.20074 · Cited by 26 · see citing works
Self-citationHoare, T. R., Bellas, E., Zurakowski, D., et al. (2009) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32420 · Cited by 20 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164 · see citing works
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645 · see citing works
Metal Nanoparticles in Alzheimer’s Disease
Behera, A., Sa, N., Pradhan, S. P., Swain, S., & Sahu, P. K. (2023) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-220112 · Cited by 50 · see citing works
- Authors
- Kohane, D. S., & Langer, R.
- Affiliations
- Harvard University (US)
- Corresponding author
- Kohane, Daniel S.
- ORCID
- Kohane, Daniel S.
- Venue
- Chem. Sci.
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2010
- Volume
- 1
- Issue
- 4
- Pages
- 441-446
- ISSN
- 2041-6520 (ISSN-L)
- 2041-6539
- OpenAlex
- W2076500439
- Cited by
- 307
- References
- 45
- Citations by year
- 2026: 11 · 2025: 23 · 2024: 16 · 2023: 26 · 2022: 18 · 2021: 17 · 2020: 20 · 2019: 17 · 2018: 24 · 2017: 15 · 2016: 17 · 2015: 19 · 2014: 23 · 2013: 15 · 2012: 28
- FWCI
- 13.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Science (publishedVersion)
- Funders
- National Institute of General Medical Sciences
- National Institute of Biomedical Imaging and Bioengineering
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- biocompatibility, drug delivery systems, drug delivery devices, biomaterials
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review